Get 20% lifetime commission for referring investors to digrin.com
here.
4D Molecular Therapeutics, Inc. ( FDMT) - Key Metrics
FDMT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.05 | -$1.04 | -$1 | -$1 |
| 2026Q1 | $0.04 | -$1.01 | -$1 | -$1 |
| 2025Q4 | $1.47 | $0.33 | $0.49 | $0.48 |
| 2025Q3 | $0 | -$1.01 | -$0.83 | -$0.83 |
| 2025Q2 | $0 | -$0.98 | -$0.78 | -$0.78 |
FDMT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.20 |
| 2026Q1 | 0% | -2.30 |
| 2025Q4 | 0% | 5.51 |
| 2025Q3 | 0% | -2.15 |
| 2025Q2 | 0% | -0.95 |
FDMT
Price: $12.14
52 week price:
Earnings Per Share: -2.63 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 192795
Market Capitalization: 667.8 million